The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Article Properties
Cite
Verdecchia, Paolo, et al. “The Pivotal Link Between ACE2 Deficiency and SARS-CoV-2 Infection”. European Journal of Internal Medicine, vol. 76, 2020, pp. 14-20, https://doi.org/10.1016/j.ejim.2020.04.037.
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine, 76, 14-20. https://doi.org/10.1016/j.ejim.2020.04.037
Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine. 2020;76:14-20.
Refrences
Refrences Analysis
The category Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system 57 is the most frequently represented among the references in this article. It primarily includes studies from Hypertension The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Citations Analysis
The first research to cite this article was titled Angiotensin-Converting-Enzyme 2 and SARS-CoV2: A Dangerous Liaison and was published in 2020. The most recent citation comes from a 2024 study titled Angiotensin-Converting-Enzyme 2 and SARS-CoV2: A Dangerous Liaison . This article reached its peak citation in 2021 , with 331 citations.It has been cited in 527 different journals, 29% of which are open access. Among related journals, the Frontiers in Immunology cited this research the most, with 24 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year